Autumn

Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program

Retrieved on: 
星期二, 五月 7, 2024

TAMPA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2024.

Key Points: 
  • The company expects to fund the share repurchase program using a combination of existing cash reserves and future cash flows.
  • Total revenues were $167.1 million in the first quarter of 2024, versus $160.3 million reported for the first quarter of 2023.
  • First quarter 2024 iovera° net product sales were $5.0 million, versus $4.0 million reported for the first quarter of 2023.
  • Adjusted EBITDA was $44.6 million in the first quarter of 2024, compared to $41.9 million in the first quarter of 2023.

Mouser Electronics Supports MATHCOUNTS Program, Investing in the Engineers of Tomorrow

Retrieved on: 
星期二, 五月 7, 2024

Mouser Electronics , Inc., the New Product Introduction (NPI) leader™ empowering innovation, today proudly announces its continued sponsorship of MATHCOUNTS , an engaging math program for middle schoolers.

Key Points: 
  • Mouser Electronics , Inc., the New Product Introduction (NPI) leader™ empowering innovation, today proudly announces its continued sponsorship of MATHCOUNTS , an engaging math program for middle schoolers.
  • View the full release here: https://www.businesswire.com/news/home/20240507210183/en/
    Mouser Electronics proudly announces its sponsorship of MATHCOUNTS, an engaging math program for students that hosts live competitions at the school, chapter, state and national levels.
  • "By sponsoring STEM programs like MATHCOUNTS, we hope to instill a passion for science, technology, engineering or math in our future mathematicians, engineers and problem solvers."
  • To learn more about how Mouser supports MATHCOUNTS, visit https://www.mouser.com/mathcounts/ .

Upbeat Teams Up with Jefferson County to Build a Successful Teacher Retention Strategy

Retrieved on: 
星期三, 五月 8, 2024

LOUISVILLE, Ky., May 8, 2024 /PRNewswire-PRWeb/ -- Upbeat, K-12 research and consulting company focused on teacher retention, and Jefferson County Public Schools (JCPS), the 30th largest school district in the US, today announced the release of an insightful case study spotlighting successful teacher retention strategies. The study showcases the innovative initiatives implemented by JCPS to cultivate a positive and supportive professional environment for educators. The report is authored by Dr. Geoff Marietta, a former K-12 educator, entrepreneur-in-residence at the University of the Cumberlands, and co-author of research and books including Rural Education in America, Improving Education Together, and Achieving Coherence in District Improvement.

Key Points: 
  • LOUISVILLE, Ky., May 8, 2024 /PRNewswire-PRWeb/ -- Upbeat, K-12 research and consulting company focused on teacher retention, and Jefferson County Public Schools (JCPS), the 30th largest school district in the US, today announced the release of an insightful case study spotlighting successful teacher retention strategies.
  • - Dr. Aimee Green-Webb, Chief of Human Resources, Jefferson County Public Schools
    In Fall 2020, JCPS embarked on a proactive journey to address teacher retention challenges by partnering with Upbeat.
  • The district piloted Upbeat's Engagement Survey and Leadership Coaching program in fall 2020, to better understand what is driving teacher retention and improve teacher satisfaction.
  • Within the initial two years of partnership, teacher retention in the pilot schools increased by over 12% to 84.7%.

PNC, TCW Partner To Expand Capabilities, Create Private Credit Platform

Retrieved on: 
星期一, 五月 6, 2024

PITTSBURGH and LOS ANGELES, May 6, 2024 /PRNewswire/ -- The PNC Financial Services Group, Inc. ("PNC"), one of the largest diversified financial institutions in the U.S., and the TCW Group, Inc. ("TCW"), a leading global asset manager, today announced they are partnering to deliver private credit solutions to middle market companies.

Key Points: 
  • The new joint strategy will focus primarily on directly originated, senior secured cash-flow and asset-based loans to both sponsored and non-sponsored middle market companies.
  • "We are thrilled to partner with PNC to expand our direct lending capabilities and provide financing to a critical segment of U.S. companies, as well as offer a differentiated investment solution for clients," said Katie Koch, president and CEO of TCW.
  • "Combining the power and legacy of PNC's broad lending capabilities with TCW's private credit group will deliver significant benefit to companies seeking growth opportunities," said William S. Demchak, chairman and chief executive officer of PNC.
  • PNC and TCW will establish a team to manage all of the strategy's investment activities including origination, underwriting, and portfolio management.

Nike Water Polo Camps Announces 2024 Summer Camps Lineup with 2 new sessions

Retrieved on: 
星期四, 五月 2, 2024

SAN RAFAEL, Calif., May 2, 2024 /PRNewswire-PRWeb/ -- US Sports Camps, the official provider of Nike Sports Camps, is excited to announce the addition of two new water polo camp locations for 2024. This year, water polo campers will register for camp sessions at The Cate School (CA) and Mercyhurst University (PA).

Key Points: 
  • US Sports Camps, the official provider of Nike Sports Camps, is excited to announce the addition of two new water polo camp locations for 2024.
  • This year, water polo campers will register for camp sessions at The Cate School (CA) and Mercyhurst University (PA).
  • SAN RAFAEL, Calif., May 2, 2024 /PRNewswire-PRWeb/ -- US Sports Camps, the official provider of Nike Sports Camps, is excited to announce the addition of two new water polo camp locations for 2024.
  • Unlike most water polo camps, Nike Water Polo Camps is a year-round camp operation, offering weekend clinics and full-week camps in the Winter, Spring, Summer, and Fall.

United Basketball League Announces Team Locations in Indiana and Texas Ahead of September Showcase

Retrieved on: 
星期四, 五月 2, 2024

HOUSTON, May 2, 2024 /PRNewswire-PRWeb/ -- The United Basketball League (UBL), a professional basketball organization geared toward domestic teams, player development, and community engagement, today announced the locations of the 16 teams across Indiana and Texas that will participate in the league's inaugural September 2024 season.

Key Points: 
  • "As we approach the UBL Showcase in September, we're thrilled to finally be able to share where this league will have a foothold in both Indiana and Texas," said Ricky Davis, Co-Founder & Vice Chairman of the United Basketball League.
  • During June 2024, the UBL Combine will journey across Texas and Indiana, scouting players and offering them the opportunity to showcase their skills to earn a spot on the roster.
  • Committed to its mission, the UBL aims to support local talent in launching or advancing their basketball careers beyond the conventional opportunities available today.
  • Coaches and staff, ambassadors, and other individual details on the Fall season will be provided in the near future.

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

Retrieved on: 
星期三, 五月 1, 2024

VANCOUVER, BC, May 1, 2024 /PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%. According to experts at last year's annual American Society of Clinical Oncology (ASCO) meeting, a little-known bacteria could be behind the rising rates of cancer in people under 40, along with pointing towards bad habits such as highly-processed diets and heavy alcohol use being potential catalysts. While five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet these challenges head on with new treatments and safeguards against cancer, including recent developments from companies such as BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD), ImmunityBio, Inc. (NASDAQ: IBRX), and MacroGenics, Inc. (NASDAQ: MGNX).

Key Points: 
  • A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%.
  • "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases," said Kenneth Kovan, President and Chief Operating Officer of BioVaxys.
  • The joint Moderna/Merck efforts are also testing the vaccine with Keytruda against other tumor types, including non-small cell lung cancer.
  • This shot is designed to train the immune system to recognize and attack specific mutations in cancer cells.

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

Retrieved on: 
星期三, 五月 1, 2024

VANCOUVER, BC, May 1, 2024 /PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%. According to experts at last year's annual American Society of Clinical Oncology (ASCO) meeting, a little-known bacteria could be behind the rising rates of cancer in people under 40, along with pointing towards bad habits such as highly-processed diets and heavy alcohol use being potential catalysts. While five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet these challenges head on with new treatments and safeguards against cancer, including recent developments from companies such as BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD), ImmunityBio, Inc. (NASDAQ: IBRX), and MacroGenics, Inc. (NASDAQ: MGNX).

Key Points: 
  • A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%.
  • "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases," said Kenneth Kovan, President and Chief Operating Officer of BioVaxys.
  • The joint Moderna/Merck efforts are also testing the vaccine with Keytruda against other tumor types, including non-small cell lung cancer.
  • This shot is designed to train the immune system to recognize and attack specific mutations in cancer cells.

Interplay Learning Launches New Enterprise Career Development Platform, Empowering Organizations to Simplify, Scale and Succeed

Retrieved on: 
星期三, 五月 1, 2024

AUSTIN, Texas, May 1, 2024 /PRNewswire/ -- Interplay Learning, the leading provider of immersive skilled trades training, announced today the launch of Interplay Enterprise. Shaped by customer insights, this immersive career development platform introduces exciting new features designed to help enterprises elevate the skills of their entire workforce, streamline operations, and improve retention.

Key Points: 
  • AUSTIN, Texas, May 1, 2024 /PRNewswire/ -- Interplay Learning , the leading provider of immersive skilled trades training, announced today the launch of Interplay Enterprise.
  • Interplay Enterprise simplifies career development by providing an all-in-one platform for company-wide learning.
  • "The latest evolution of our industry-leading solution allows organizations to simplify career development, scale their training, and succeed in building a strong, skilled workforce," said Doug Donovan, CEO and founder of Interplay Learning.
  • World-class enterprise service and support: Interplay Learning is a strategic partner for career development consulting, implementation, insights, and U.S.-based support.

University of St. Augustine for Health Sciences Fills Healthcare Industry Shortages with New Innovative Programs

Retrieved on: 
星期二, 四月 16, 2024

These programs aim to prepare students for advanced clinical practice and leadership roles in top healthcare specialties.

Key Points: 
  • These programs aim to prepare students for advanced clinical practice and leadership roles in top healthcare specialties.
  • In the healthcare disciplines that USAHS addresses, practitioner shortages are growing while demand for treatment is increasing; therefore, boosting the educational pipeline has become more critical than ever.
  • Dedicated to graduate studies in health sciences, USAHS fills the healthcare industry pipeline gaps through innovative blended online and hands-on programs, allowing students to live almost anywhere in the U.S. while obtaining their master's or doctorate degrees.
  • They also ensure that the University’s programs prepare graduate students for their future careers and fill the existing healthcare pipeline gaps.